Inactive Instrument

Highlights GENB AS Other OTC

Equities

US3723032062

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'	15/05	MT
Genmab A/S to Present New and Updated Results from Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies At the 2024 European Hematology Association Congress	14/05	CI
GENMAB : A good start to 2024; guidance unchanged	03/05
Genmab Posts Q1 Net Profit Surge; Revenue Jumps	03/05	MT
Genmab Reports Higher Interim Q1 Results; Maintains 2024 Guidance	02/05	MT
Genmab A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05	CI
Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer	30/04	MT
Pfizer Inc. and Genmab A/S Announce FDA Grants Full Approval for TIVDAK to Treat Recurrent or Metastatic Cervical Cancer	30/04	CI
Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	16/04	MT
Health Care Slips on Risk Bias -- Health Care Roundup	12/04	DJ
Health Care Flat on Rotation to Rate-Sensitive Sectors -- Health Care Roundup	04/04	DJ
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET	03/04	DJ
Global markets live: Swiss Re, Intel, Walt Disney, Paramount, Microsoft...	03/04
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET	03/04	DJ
Correction to Genmab Article	03/04	DJ
Genmab: acquisition of ProfoundBio greeted without emotion	03/04	CF
News Highlights : Top Company News of the Day - Wednesday at 7 AM ET	03/04	DJ
Genmab A/S Re-Affirms Revenue Guidance for the Year 2024	03/04	CI
European Midday Briefing : Stocks Continue to Struggle Despite Cooling Inflation	03/04	DJ
News Highlights : Top Company News of the Day - Wednesday at 5 AM ET	03/04	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 10:38 pm IST